AMBU B Stock Overview
Develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 129.35 |
| 52 Week High | DKK 154.60 |
| 52 Week Low | DKK 65.62 |
| Beta | 0.77 |
| 11 Month Change | -4.68% |
| 3 Month Change | -3.43% |
| 1 Year Change | 89.05% |
| 33 Year Change | -30.48% |
| 5 Year Change | 20.33% |
| Change since IPO | 7,453.29% |
Recent News & Updates
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
Sep 02
Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital
Aug 06Recent updates
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next
Sep 02Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital
Aug 06Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
Apr 06Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
Mar 14Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 01A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price
Jan 02Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?
Oct 31Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Sep 22Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Aug 19Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?
Jul 12Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture
Jun 22Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet
May 07Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture
Mar 24We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt
Jan 20Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around
Dec 08Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?
Sep 23Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Sep 08We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt
Aug 21Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital
Jun 06These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively
May 19Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Jan 23Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?
Dec 12Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Oct 04Shareholder Returns
| AMBU B | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | 2.8% | 1.9% | -0.9% |
| 1Y | 89.1% | 22.8% | 19.7% |
Return vs Industry: AMBU B exceeded the Danish Medical Equipment industry which returned 23.8% over the past year.
Return vs Market: AMBU B exceeded the Danish Market which returned 19.8% over the past year.
Price Volatility
| AMBU B volatility | |
|---|---|
| AMBU B Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in DK Market | 8.9% |
| 10% least volatile stocks in DK Market | 2.4% |
Stable Share Price: AMBU B's share price has been volatile over the past 3 months compared to the Danish market.
Volatility Over Time: AMBU B's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Danish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 4,900 | Britt Jensen | www.ambu.com |
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| AMBU B fundamental statistics | |
|---|---|
| Market cap | DKK 34.46b |
| Earnings (TTM) | DKK 450.00m |
| Revenue (TTM) | DKK 5.26b |
76.6x
P/E Ratio6.5x
P/S RatioIs AMBU B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBU B income statement (TTM) | |
|---|---|
| Revenue | DKK 5.26b |
| Cost of Revenue | DKK 2.16b |
| Gross Profit | DKK 3.10b |
| Other Expenses | DKK 2.65b |
| Earnings | DKK 450.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 05, 2024
| Earnings per share (EPS) | 1.69 |
| Gross Margin | 58.88% |
| Net Profit Margin | 8.55% |
| Debt/Equity Ratio | 0% |
How did AMBU B perform over the long term?
See historical performance and comparison